Marino steps down as Trump’s medication czar nominee

Marino steps down as Trump's drug czar nominee

After general public outcry, President Trump announced that their choice for drug czar experienced withdrawn his name from consideration, whilst praising the embattled politician since “a fine man and a great congressman.”

Trump revealed that Rep. Ben Marino, R-Pa., is no longer his nominee for the top position at the Office associated with National Drug Control Policy upon Twitter Tuesday morning.

The president had nominated Marino, an early supporter of his candidacy, to the prestigious post responsible for establishing strategies to stop drug abuse and market access to substance abuse treatments last 30 days. But an astonishing exposé by the Washington Post and “60 Minutes” upon Sunday about Marino’s ties in order to drug companies drew fierce critique.

Marino, who has accepted large contributions from the pharmaceutical industry, was the principal sponsor of the Ensuring Patient Entry and Effective Drug Enforcement Work, passed by Congress last year. The particular legislation contained certain highly specialized provisions that weakened the Medication Enforcement Administration’s authority to stop dubious opioid shipments. For years, drug businesses had reportedly ignored DEA alerts to stop the suspicious sales associated with hundreds of millions of pills, which led to billions of dollars in sales.

President Trump said Rep. Tom Marino, R-Pa., has withdrawn his name through consideration to be the country’s drug czar. (Photos: Bill Clark/CQ Roll Call/Getty Images, Pablo Martinez Monsivais/AP)

DEA whistleblowers say the agency fought Marino’s bill for years, but key users of Congress and lobbyists eventually prevailed. Opponents say it added to the growing opioid crisis.

As opioids flood U. S. roads, drug overdoses are the nation’s top cause of accidental death. According to the Facilities for Disease Control, roughly 91 Americans die from an opioid overdose every day and more than 33, 000 Americans died from opioid overdoses in 2015. Early information suggest that this figure will be increased for 2016.

Trump was questioned whether he still had self-confidence in Marino during a press meeting in the White House Rose Backyard on Monday afternoon. He mentioned he had seen the report plus would “take it very seriously.”

“This country — and frankly, the world — has a drug problem. The world has a drug problem. But we have it, and we’re going to do something about it,” Trump said. “So we’re going to have a major announcement on that problem next week. We’re gonna be looking into Tom.”

Chuck Schumer, D-NY, said in a declaration Tuesday that Marino made the ideal decision by withdrawing but “the fact that he was nominated to begin with is further evidence that when considering the opioid crisis, the Trump administration talks the talk, yet refuses to walk the walk.

“The opioid crisis demands that the following drug czar is solely centered on getting communities across the country the help they will desperately need, â€? Schumer carried on. “I hope the Trump administration nominates someone that fits the bill.”

Similarly, Sen. Claire McCaskill, the particular top-ranking Democrat on the Homeland Safety and Governmental Affairs Committee, launched the following statement:

“I think this is the right decision, and I look forward to the Administration nominating a leader that can aggressively bring to bear every tool the government has to confront what is unquestionably a national public health crisis.”

Marino’s office have not responded to a request for comment through Yahoo News.

Read more through Yahoo News:



Please enter your comment!
Please enter your name here